Skip to content

EBIT at other companies

Abbott logo
AbbottABT
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Calculated from Bio-Rad Laboratories, Inc.’s reported figures.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s EBIT?
Bio-Rad Laboratories, Inc. (BIO.B) reported EBIT of $34.1M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s EBIT changed year-over-year?
Bio-Rad Laboratories, Inc.'s EBIT increased by 43.9% year-over-year, from $23.7M to $34.1M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s EBIT?
Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s EBIT has grown at a 22.0% compound annual growth rate (CAGR), from $500.34M to $1.11B.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.